Sky Medical Technology appoints Fiona Young to lead adoption of geko™ device in wound care

ByLance T. Lee

Oct 14, 2022

[ad_1]

  • Sky Medical Technology (Sky) appoints seasoned sales development professional to drive market adoption of geko™ device for healing leg ulcers
  • The geko™ is a wearable medical device that increases blood flow in the leg to transport oxygenated blood to the wound edge and bed.

LONDON, October 14, 2022 /PRNewswire/ — Sky Medical Technology Ltd (Sky), parent company of Firstkind Ltd, today announced the appointment of Fiona Young as director of its wound care business. Fiona will lead and develop the sales and marketing strategy for Sky’s geko™ devices in wound care.

Sky is a British manufacturer of wearable medical devices designed to treat chronic wounds that afflict millions of people around the world every year. The Global Wound Care Market is Expected to Reach $27.2 billion by 2027, driven by the growth of an aging population and the increasing use of technological advances in innovative wound care products.

Fiona’s appointment brings Sky a proven track record of building international business success in the wound care market. Over her 20-year career, Fiona has held sales development roles at Crawford Healthcare and Lohmann & Rauscher, helping to introduce and integrate new products into wound care journeys – and most recently as a manager of international marketing and direct-to-consumer sales at Flen Health, a company that provides innovation in skin healing.

Commenting on her appointment, Fiona said: “I am delighted to join Sky at this important time in the company’s development. Sky has an exceptionally dynamic technology platform with multiple significant market opportunities, wound therapy being one of the largest. I am delighted to work with the Sky team and excited to lead a clinical partner promotion program that will help drive adoption of the geko™ device The market is ripe for the introduction of the proven geko™ device in clinic, an innovation capable of improving the lives of millions of people living with chronic wounds.”

“It is with great pleasure that we welcome Fiona Young to the Sky team. Fiona’s extensive wound care business experience makes her ideal for the development and execution of our wound care business strategy. Fiona’s expertise will provide highly relevant and invaluable leadership in engaging wound care professionals eager to embrace innovation for better patient outcomes,” commented Bernard RossCEO and Founder of Sky.

About the geko™ device

Worn on the knee, the geko™, a neuromuscular electrical stimulation device, gently stimulates the common peroneal nerve by activating muscle pumps in the calf and foot, resulting in increased venous, arterial and microcirculatory blood flow – carrying oxygenated blood to the wound edge and bed to promote healing in patients with lower extremity wounds.

About Sky Medical Technology Ltd

Sky Medical Technology (Sky) is a UK-based medical device company. Using its innovative non-invasive neuromuscular electrical stimulation mechanism, Sky has developed a breakthrough NMES technology platform, OnPulse™, integrated into its industry-leading product, the geko™ device. The company develops a range of products tailored to the needs of different areas of medical application, selling both directly and through strategic partnerships or distributors in each major clinical area. Areas of clinical interest include chronic wound healing, treatment and prevention of edema (swelling), and prevention of venous thromboembolism (VTE). The goal of each therapy is to partner with healthcare professionals to improve clinical outcomes and patient care while reducing costs to healthcare systems.

Photo: https://mma.prnewswire.com/media/1919646/Fiona_Young.jpg
Photo: https://mma.prnewswire.com/media/1919647/geko.jpg
Logo: https://mma.prnewswire.com/media/1340942/Sky_Medical_Logo.jpg
Logo: https://mma.prnewswire.com/media/1765040/Firstkind_Logo.jpg

SOURCESky Medical Technology

[ad_2]
Source link